pharmaphorum| News & views on pharma and biotech’s evolving future

Patients

Start early - live well: Addressing the mental health crisis

According to the World Health Organization (WHO), globally, one in seven 10-19-year-olds experiences a mental disorder, accounting for

R&D

The growth of radiotherapeutics: Addressing supply chain com...

Players, current and emergent, should prepare for complexities in the supply chain as radiotherapeutics continues to rise.

Market Access

How Trump's pharma tariffs will hurt industry and patients a...

Patients

Jonah Comstock at AAPS interviewing Mehul Desai

Challenging conventional wisdom on injectables, with Mehul D...

Mehul Desai, VP of medical affairs at Enable Injections, sat down with pharmaphorum editor-in-chief Jonah Comstock at AAPS.

News

US imposes limits on COVID-19 boosters and new jabs

The FDA has introduced a stricter set of policies around COVID-19 vaccines, including requiring clinical trials for new shots in some cases.

Featured Content

R&D

The growth of radiotherapeutics: Addressing supply chain com...

Players, current and emergent, should prepare for complexities in the supply chain as radiotherapeutics continues to rise.

Market Access

How Trump's pharma tariffs will hurt industry and patients a...

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Market Access

Bridging research and clinical guidelines – interactive stra...

Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.

Market Access

pharmaphorum podcast Episode 179a - Cen Zorlular, Er-Kim Pharmaceuticals

EAPs: Market access outside of the US and Western Europe

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Cem Zorlular, CEO of Er-Kim Pharmaceuticals about early access programmes.

Patients

Challenging conventional wisdom on injectables, with Mehul D...

Mehul Desai, VP of medical affairs at Enable Injections, sat down with pharmaphorum editor-in-chief Jonah Comstock at AAPS.

R&D

Life Sciences Industry Report - Part 7 cover image

Life Sciences Industry Report - Biologics and Generics

The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.

Newsletters and Deep Dive
digital magazine

Latest News

News

US imposes limits on COVID-19 boosters and new jabs

The FDA has introduced a stricter set of policies around COVID-19 vaccines, including requiring clinical trials for new shots in some cases.

News

UK to start "world first" gonorrhoea vaccine programme

As infections rise, a world-first gonorrhoea vaccine programme has been launched in the UK.

News

Beckley Psytech's chief scientific and medical officer Dr Rob Conley

Beckley's psychedelic med inches forward in depression

UK psychedelic medicines developer Beckley Psytech has said its candidate for treatment-resistant depression has enhanced the effect of standard antidepressants in a phase 2 trial.

News

UK trumpets £1bn investment plan from BioNTech

BioNTech has said it will commit up to £1bn in investment in the UK over the next decade, in what has been described as a "template" for the sector.

Views & Analysis

R&D

The growth of radiotherapeutics: Addressing supply chain com...

Players, current and emergent, should prepare for complexities in the supply chain as radiotherapeutics continues to rise.

Patients

Challenging conventional wisdom on injectables, with Mehul D...

Mehul Desai, VP of medical affairs at Enable Injections, sat down with pharmaphorum editor-in-chief Jonah Comstock at AAPS.

Patients

Start early - live well: Addressing the mental health crisis

According to the World Health Organization (WHO), globally, one in seven 10-19-year-olds experiences a mental disorder, accounting for

Patients

Real-world evidence in CNS research: Past, present, future

Large-scale, multi-country real-world evidence (RWE) studies—including in Central Nervous System (CNS) indications—have the potential to deliver critical new insights.

Deep Dive

Market Access

How Trump's pharma tariffs will hurt industry and patients a...

Market Access

The evolution of real-world evidence

Market Access

The smarter spending playbook: Reviving stagnant pharma prod...

Market Access

From market access to real-world patient access: Closing the...

White Papers & Webinar

Digital

Linear visual illustration of nodes in an arrow shape

Enabling Digitally Enhanced Care for Rare Diseases in Europe

Integrating AI and Connected Care Technologies in Lysosomal Storage Disease Patient Journeys

Market Access

Bridging research and clinical guidelines – interactive stra...

Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.

R&D

Life Sciences Industry Report - Biologics and Generics

The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.

R&D

Life Sciences Industry Report - Rare Disease Space

There are some 7,000 known rare diseases in the world, yet, multiple challenges and unmet needs remain when it comes to therapies for these diseases.

Podcasts & Video

Patients

Challenging conventional wisdom on injectables, with Mehul D...

Mehul Desai, VP of medical affairs at Enable Injections, sat down with pharmaphorum editor-in-chief Jonah Comstock at AAPS.

Market Access

EAPs: Market access outside of the US and Western Europe

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Cem Zorlular, CEO of Er-Kim Pharmaceuticals about early access programmes.

R&D

Jonah Comstock interviews Dr Dhaval Shah at AAPS

Modelling biologics: Challenges and opportunities, with Dr D...

From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.

Digital

Eric Luellen and Jonah Comstock interview at AAPS

AI-powered drug discovery is outpacing regulators, with Eric...

During the AAPS National Biotech Conference 2025, pharmaphorum’s Jonah Comstock sat down with Eric Luellen, the founder and CTIO of Turing Biosciences